|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
PURCHASE
|
Jan. 17, 2022 |
$$1,000-$15,000 |
Feb. 23, 2022 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
PURCHASE
|
Dec. 23, 2021 |
$$1,000-15,000 |
Jan. 27, 2022 |
|
Josh Gottheimer
|
house |
Phreesia, Inc. (PHR) |
PHR |
STOCK |
Purchase
|
Dec. 15, 2021 |
$$1,001 - $15,000 |
Jan. 10, 2022 |
|
Zoe Lofgren
|
house |
danaher Corporation (dHR) |
DHR |
STOCK |
Purchase
|
Sept. 30, 2021 |
$$1,001 - $15,000 |
Oct. 7, 2021 |
|
Diana Harshbarger
|
house |
C.H. ROBINSON WORLDWIDE INC |
CHRW |
STOCK |
X
|
July 29, 2021 |
$X |
Aug. 27, 2021 |
|
Diana Harshbarger
|
house |
C.H. ROBINSON WORLDWIDE INC |
CHRW |
STOCK |
X
|
July 29, 2021 |
$X |
Aug. 27, 2021 |
|
Diana Harshbarger
|
house |
C.H. ROBINSON WORLDWIDE INC |
CHRW |
STOCK |
X
|
July 29, 2021 |
$X |
Aug. 27, 2021 |
|
Carol Devine Miller
|
house |
Hormel Foods Corporation (HRL) |
HRL |
STOCK |
Sale (partial)
|
July 28, 2021 |
$$15,001 - $50,000 |
Sept. 2, 2022 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
PURCHASE
|
July 12, 2021 |
$$50,001-@100,000 |
June 17, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
PURCHASE
|
July 12, 2021 |
$$50,001-@100,000 |
June 17, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Exchange
|
July 5, 2021 |
$Over $50,000,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Exchange
|
July 5, 2021 |
$$25,000,001-$50,000,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Exchange
|
July 5, 2021 |
$$5,000,001-$25,000,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Exchange
|
July 5, 2021 |
$$500,001-$1,000,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Exchange
|
July 5, 2021 |
$$250,001-$500,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Exchange
|
July 5, 2021 |
$$15,001-$50,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Exchange
|
July 5, 2021 |
$$50,001-$100,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Exchange
|
July 5, 2021 |
$$1,000-B$5,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Purchase
|
July 5, 2021 |
$$500,001-$1,000,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Purchase
|
July 5, 2021 |
$$250,001-$500,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Purchase
|
July 5, 2021 |
$$100,001-$250,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Purchase
|
July 5, 2021 |
$$50,001-$100,000 |
July 16, 2021 |
|
Michael T. McCaul
|
house |
United Therapeutics Corp |
UTHR |
STOCK |
Exchange
|
July 5, 2021 |
$$100,001-$250,000 |
July 16, 2021 |
|
Kevin Hern
|
house |
Danaher Corporation (DHR) |
DHR |
STOCK |
Purchase
|
July 1, 2021 |
$$50,001 - $100,000 |
Sept. 15, 2021 |
|
John Curtis
|
house |
Danaher Corporation (DHR) |
DHR |
STOCK |
Sale (partial)
|
June 22, 2021 |
$$1,001 - $15,000 |
July 6, 2021 |